WBA Stock Up 0.50% on May 11, 2026 – NASDAQ Activity

Walgreens Boots Alliance, Inc. (WBA) gained momentum on May 11, 2026, with WBA stock climbing 0.50% to close at $11.98 USD on NASDAQ. The pharmacy-led retailer saw exceptional trading activity, with volume reaching 452 million shares, a remarkable 26.7x above its daily average of 16.9 million. This intraday surge reflects renewed investor interest in the healthcare sector’s largest pharmacy chain. WBA operates over 13,000 retail locations globally and manages specialty pharmacy services across the United States and International segments. The stock’s movement today signals active market participation in this established healthcare name.

WBA Stock Performance and Price Action

WBA stock opened and closed at $11.98, maintaining steady ground throughout the session. The stock trades well below its 52-week high of $13.25 but above its 52-week low of $8.08, reflecting the company’s volatile year. Year-to-date, WBA stock has surged 30.36%, while the one-year return stands at 32.23%, showing recovery momentum.

The 50-day moving average sits at $11.66, just below today’s price, suggesting short-term support. The 200-day moving average of $10.81 indicates longer-term upward positioning. With a market cap of $10.37 billion USD, WBA remains a significant player in the healthcare retail space despite ongoing operational challenges.

Trading Volume and Market Sentiment

Today’s trading activity was extraordinary, with volume exploding to 452 million shares, dwarfing the typical daily average of 16.9 million. This 26.7x relative volume surge indicates strong institutional and retail participation in WBA stock.

Technical indicators show mixed signals. The RSI reading of 100.00 suggests overbought conditions, while the ADX of 50.00 confirms a strong directional trend. The Keltner Channel middle band sits at $11.93, providing dynamic support near today’s close. Money Flow Index at 50.00 indicates neutral momentum, suggesting the volume spike may reflect profit-taking or position adjustments rather than sustained buying pressure.

Financial Health and Valuation Metrics

WBA stock faces significant profitability headwinds. The company reported a negative EPS of -$7.29, resulting in a negative PE ratio of -1.64. Net profit margin stands at -2.81%, indicating the company is currently unprofitable on a trailing-twelve-month basis.

However, valuation metrics appear attractive. The price-to-sales ratio of 0.089 is exceptionally low, suggesting the market values WBA stock at a steep discount. The price-to-book ratio of 1.44 indicates modest premium to book value. Debt-to-equity ratio of 4.04 reveals elevated leverage, a concern for long-term stability. The dividend yield of 2.09% provides income support, though sustainability remains questionable given negative earnings.

Analyst Outlook and Company Rating

Meyka AI rates WBA with a grade of C+, reflecting mixed fundamentals and operational challenges. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating suggests a HOLD recommendation for current investors.

Analyst consensus shows cautious sentiment, with one sell rating and no buy recommendations in recent coverage. The company faces headwinds from negative return on equity of -38.81% and negative return on assets of -4.74%. Yet track WBA on Meyka for real-time updates on analyst changes and price targets. These grades are not guaranteed and we are not financial advisors.

Final Thoughts

WBA stock gained 0.50% on May 11, 2026, driven by strong trading volume and attractive dividend yield of 2.09%, appealing to income investors. However, the company faces profitability challenges and declining returns on capital. While Walgreens’ global retail presence and specialty pharmacy services offer structural advantages, fundamental operational improvements are necessary for sustained recovery. Investors should watch upcoming earnings announcements closely before committing to this value play.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.